NASDAQ:SGRY Surgery Partners (SGRY) Stock Price, News & Analysis $22.83 -0.71 (-3.02%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$22.84 +0.01 (+0.02%) As of 05:24 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Surgery Partners Stock (NASDAQ:SGRY) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Surgery Partners alerts:Sign Up Key Stats Today's Range$22.25▼$23.2750-Day Range$20.32▼$25.8752-Week Range$19.50▼$33.97Volume1.27 million shsAverage Volume1.07 million shsMarket Capitalization$2.91 billionP/E RatioN/ADividend YieldN/APrice Target$36.63Consensus RatingModerate Buy Company OverviewSurgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.Read More… Remove Ads Surgery Partners Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks53rd Percentile Overall ScoreSGRY MarketRank™: Surgery Partners scored higher than 53% of companies evaluated by MarketBeat, and ranked 480th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingModerate Buy Consensus RatingSurgery Partners has received a consensus rating of Moderate Buy. The company's average rating score is 2.78, and is based on 7 buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageSurgery Partners has only been the subject of 2 research reports in the past 90 days.Read more about Surgery Partners' stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth20.90% Earnings GrowthEarnings for Surgery Partners are expected to grow by 20.90% in the coming year, from $0.67 to $0.81 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Surgery Partners is -47.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Surgery Partners is -47.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioSurgery Partners has a PEG Ratio of 19.21. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioSurgery Partners has a P/B Ratio of 0.95. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Surgery Partners' valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted13.48% of the float of Surgery Partners has been sold short.Short Interest Ratio / Days to CoverSurgery Partners has a short interest ratio ("days to cover") of 8.Change versus previous monthShort interest in Surgery Partners has recently increased by 2.00%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSurgery Partners does not currently pay a dividend.Dividend GrowthSurgery Partners does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted13.48% of the float of Surgery Partners has been sold short.Short Interest Ratio / Days to CoverSurgery Partners has a short interest ratio ("days to cover") of 8.Change versus previous monthShort interest in Surgery Partners has recently increased by 2.00%, indicating that investor sentiment is decreasing. News and Social Media2.4 / 5News Sentiment1.29 News SentimentSurgery Partners has a news sentiment score of 1.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Surgery Partners this week, compared to 5 articles on an average week.Search InterestOnly 1 people have searched for SGRY on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Surgery Partners insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,717,860.00 in company stock.Percentage Held by InsidersOnly 2.30% of the stock of Surgery Partners is held by insiders.Read more about Surgery Partners' insider trading history. Receive SGRY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Surgery Partners and its competitors with MarketBeat's FREE daily newsletter. Email Address SGRY Stock News HeadlinesSurgery Partners, Inc. (NASDAQ:SGRY) Insider Sells $76,028.04 in StockMarch 14, 2025 | insidertrades.comBrokerages Set Surgery Partners, Inc. (NASDAQ:SGRY) PT at $36.63March 27, 2025 | americanbankingnews.comTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.April 4, 2025 | Porter & Company (Ad)Surgery Partners' (SGRY) "Outperform" Rating Reaffirmed at Royal Bank of CanadaMarch 26, 2025 | americanbankingnews.comRBC Capital Sticks to Its Buy Rating for Surgery Partners (SGRY)March 25, 2025 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Aardvark Therapeutics, Inc. (AARD) and Surgery Partners (SGRY)March 10, 2025 | markets.businessinsider.comSurgery Partners (SGRY) Gets a Buy from RBC CapitalMarch 10, 2025 | markets.businessinsider.comSurgery Partners price target lowered to $28 from $32 at TD CowenMarch 5, 2025 | markets.businessinsider.comSee More Headlines SGRY Stock Analysis - Frequently Asked Questions How have SGRY shares performed this year? Surgery Partners' stock was trading at $21.17 on January 1st, 2025. Since then, SGRY shares have increased by 7.8% and is now trading at $22.83. View the best growth stocks for 2025 here. How were Surgery Partners' earnings last quarter? Surgery Partners, Inc. (NASDAQ:SGRY) released its earnings results on Monday, March, 3rd. The company reported $0.39 EPS for the quarter, topping analysts' consensus estimates of $0.38 by $0.01. The firm had revenue of $864.40 million for the quarter, compared to analysts' expectations of $828.09 million. Surgery Partners had a positive trailing twelve-month return on equity of 2.85% and a negative net margin of 2.03%. How do I buy shares of Surgery Partners? Shares of SGRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Surgery Partners own? Based on aggregate information from My MarketBeat watchlists, some other companies that Surgery Partners investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Palo Alto Networks (PANW), ServiceNow (NOW) and Adobe (ADBE). Company Calendar Last Earnings3/03/2025Today4/04/2025Next Earnings (Estimated)5/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry General medical & surgical hospitals Sub-IndustryHealthcare Current SymbolNASDAQ:SGRY CIK1638833 Webwww.surgerypartners.com Phone(615) 234-5900Fax615-234-5998Employees13,500Year FoundedN/APrice Target and Rating Average Stock Price Target$36.63 High Stock Price Target$50.00 Low Stock Price Target$28.00 Potential Upside/Downside+60.4%Consensus RatingModerate Buy Rating Score (0-4)2.78 Research Coverage9 Analysts Profitability EPS (Most Recent Fiscal Year)($1.33) Trailing P/E RatioN/A Forward P/E Ratio34.07 P/E Growth19.21Net Income$-11,900,000.00 Net Margins-2.03% Pretax Margin4.21% Return on Equity2.85% Return on Assets1.22% Debt Debt-to-Equity Ratio0.99 Current Ratio1.80 Quick Ratio1.66 Sales & Book Value Annual Sales$3.11 billion Price / Sales0.94 Cash Flow$1.60 per share Price / Cash Flow14.30 Book Value$23.99 per share Price / Book0.95Miscellaneous Outstanding Shares127,613,000Free Float124,190,000Market Cap$2.91 billion OptionableOptionable Beta2.40 Social Links 2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (NASDAQ:SGRY) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surgery Partners, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surgery Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.